Table 3. Clinical characteristics of patients bearing both a classical and an ‘other’ mutation.

Patients no.	Sex	Histology	Smoking status	Response to gefitinib	Duration
9	Male	Undifferentiated	Smoker	PD	—	L858R-L861P
11	Female	Adenocarcinoma	Never-smoker	SD	64 weeks	L858R-V843I
18	Female	Squamous	Never-smoker	PR	12 weeks	L858R-E709K